AbCellera Biologics Inc (ABCL) NPV

Sell:$3.74Buy:$3.75$0.26 (7.31%)

NASDAQ:0.94%
Market closed | Prices delayed by at least 15 minutes
Sell:$3.74
Buy:$3.75
Change:$0.26 (7.31%)
Market closed | Prices delayed by at least 15 minutes
Sell:$3.74
Buy:$3.75
Change:$0.26 (7.31%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. Its platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the challenging antibody discovery problems. It is focused on advancing an internal pipeline of programs and collaborating on drug development programs with partners. Its first two internal programs, ABCL635 and ABCL575, are in late-preclinical studies. ABCL635 is an antibody drug candidate for metabolic and endocrine conditions, and ABCL575 is an antibody drug candidate with broad potential in inflammatory conditions and autoimmune diseases and an initial indication in atopic dermatitis. ABCL575 binds OX40L to disrupt OX40/OX40L signaling, a regulator of inflammatory pathways in AD. In addition to ABCL635 and ABCL575, it is advancing a pipeline of more than 20 internal discovery programs.

Key people

Carl L.G. Hansen
Chairman of the Board, President, Chief Executive Officer, Co-Founder
Veronique Lecault
Co-Founder, Chief Operating Officer, Director
Andrew Booth
Chief Financial Officer
Tryn T. Stimart
Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer
Michael R. Hayden
Lead Independent Director
Andrew W. Lo
Independent Director
John S. Montalbano
Independent Director
Click to see more

Key facts

  • EPIC
    ABCL
  • Location
    Canada
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    CA00288U1066
  • Market cap
    $1.04bn
  • Employees
    596
  • Shares in issue
    298.48m
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.